The subject of the contract is the supply of medicinal products as part of a therapeutic health program, divided into 6 lots
Part No. 1Adalimumabum 0.04 g/0.8 ml
Part No. 2Rituximabum 500 mg/50 ml
Part No. 3Tocilizumab inj. 0.4g/20 ml and 0.08g/4 ml
Part No. 4Baricitinibum, 4 mg, tabl. Powl
Part No. 5Ethanerceptum 0,05 g/ml
Part No. 6Tofacitinibum 5 mg